ANVISA registration

VARIANT nbs Sickle Cell Program

Registration 80020690277. HEMOGLOBINA SUBTIPO - TRIAGEM NEONATAL

Registration details

Registration number80020690277
Application number25351705322201161
Technical nameHEMOGLOBINA SUBTIPO - TRIAGEM NEONATAL
Risk classIII
Published on30/01/2012
ValidityValid until 30/01/2037

Registration holder

Legal nameBIO-RAD LABORATORIOS BRASIL LTDA
CNPJ03.188.198/0001-77

Manufacturer

  • BIO-RAD LABORATORIES, INC ESTADOS UNIDOS DA AMÉRICA

Other registrations held by BIO-RAD LABORATORIOS BRASIL LTDAview all

Genscreen HIV 1/2 Versão 2

80020690044

NEW LAV BLOT I

80020690099

Família de meios de cultura seletivos para determinado grupo de micro-organismos - Bio-Rad

80020690139

Substrato de Células de Linhagem HEP2 Kallestad

80020690141

PASTOREX STAPH PLUS

80020690151

PASTOREX STREP

80020690152

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist